Skip to content

The VEPRO Trial: A Cross-Over Randomised Controlled Trial Comparing 2 Corrective Lenses for Patients With Presbyopia

The VEPRO Trial: A Cross-Over Randomised Controlled Trial Comparing 2 Corrective Lenses for Patients With Presbyopia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00635115
Acronym
VEPRO
Enrollment
127
Registered
2008-03-13
Start date
2006-02-28
Completion date
2007-01-31
Last updated
2008-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia

Brief summary

The VEPRO trial is a cross-over randomised controlled trial comparing 2 corrective lenses for patients with presbyopia. The aim of the study is to compare the effectiveness of two corrective lenses: an old generation (Varilux Comfort Orma Crizal) and a new generation (Varilux Panamic Orma Crizal) of corrective lenses prescribed in presbyopia.

Interventions

DEVICEa new generation of corrective lens for presbyopia (i.e., Varilux Panamic Orma Crizal)
DEVICEan old generation of corrective lens for presbyopia (i.e., Varilux Comfort Orma Crizal)

Sponsors

Santéclair
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
43 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* age 43 to 60 years old * outpatients wearing corrective lenses for presbyopia, referred to an optician within the last 6 months for a change in their optical correction * associated hyperopia or astigmatism, the required correction had to be ≤ 3 dioptres in that case * understanding, speaking French and able to answer a questionnaire

Exclusion criteria

* first prescription of corrective lenses for presbyopia * associated strabism * associated amblyopia * orthoptics therapy * associated anisometropia \> 1.5 dioptres * patients treated for diabetes

Design outcomes

Primary

MeasureTime frame
patient preference for a corrective lens8 weeks

Secondary

MeasureTime frame
subjective measures of different areas of visual performance.8 weeks

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026